No profile data available.
Wave Life Sciences Ltd. (WVE) is a healthcare company in the hepatic treatment pharmaceuticals industry, based in Cambridge, United States, with about 317 full-time employees.
It reported revenue of $42.73 million for fiscal year 2025, down 60.5% from fiscal year 2024, and net income of -$204.38 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $38.25 million, up 316.9% from a year before. Its market capitalization was $681.79 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders.
Wave Life Sciences reported $42.73 million in revenue for fiscal year 2025, down 60.5% from $108.30 million in fiscal year 2024. In Q1 2026 revenue was $38.25 million.
$681.79 million as of October 9, 2026.
Listed companies of a similar size in the same industry (hepatic treatment pharmaceuticals) include Arrowhead Pharmaceuticals, Inc. (ARWR), Mirum Pharmaceuticals, Inc. (MIRM), Inventiva S.a. (IVA), Sagimet Biosciences Inc. (SGMT).